/

Remix Therapeutics

Develops small molecule therapies to reprogram RNA processing.

BiotechnologyPharmaceuticals remixtx.com ↗

Company facts

Founded: 2019
Employees: 56
Headquarters: United States
Type: Private
Funding: Series B · $60M · 2024